Longboard Pharmaceuticals | 8-K: Current report
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SEKHRI PAUL J
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SCHNEIDER PHILLIP M
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lynch Casey
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Le Goff Corinne
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Aurentz Vincent
Longboard Pharmaceuticals | 8-K: Current report
Longboard Pharmaceuticals | 10-Q: Quarterly report
Longboard Pharmaceuticals | 8-K: Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Longboard Pharmaceuticals | 8-K: Current report
Longboard Pharmaceuticals | ARS: Annual Report to Security Holders
Longboard Pharmaceuticals | DEFA14A: Others
Longboard Pharmaceuticals | DEF 14A: Definitive information statements
Longboard Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Longboard Pharmaceuticals | 8-K: Current report
Longboard Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Longboard Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Longboard Pharmaceuticals | 10-K: Annual report
Longboard Pharmaceuticals | 8-K: Current report
Longboard Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(12.749%),Abigail P. Johnson(12.749%)
No Data